Umberger Traci S 4
4 · KESTRA MEDICAL TECHNOLOGIES, LTD. · Filed Jun 4, 2026
Research Summary
AI-generated summary of this filing
Kestra Medical (KMTS) Director Traci Umberger Receives RSU Award
What Happened Traci S. Umberger, General Counsel, Chief Administrative Officer and a director of Kestra Medical Technologies, Ltd. (KMTS), was granted 25,227 restricted stock units (RSUs) on June 3, 2026. The grant was recorded at $0.00 per unit (code A — award/acquisition); the RSUs convert to one common share each at settlement and have no immediate cash proceeds or sale associated with the grant.
Key Details
- Transaction date: 2026-06-03; Form 4 filed: 2026-06-04 (timely filing).
- Type: Award/acquisition of RSUs (SEC transaction code A). Price reported: $0.00 per unit.
- Quantity: 25,227 RSUs granted.
- Vesting: Subject to continued service; vesting over three years with one-third vesting on each anniversary of June 3, 2026 (per footnote).
- Shares owned after transaction: Not stated in the provided extract.
- No 10b5-1, cashless exercise, tax-withholding, or sale noted in this filing.
Context RSU grants are a common form of executive/director compensation and represent a future right to receive company shares if vesting conditions are met; they are not immediate purchases or sales. Because these RSUs vest over time, they do not indicate an immediate disposition of shares and should be viewed as part of standard compensation rather than a direct market sentiment signal.
Insider Transaction Report
- Award
Common Shares
[F1]2026-06-03+25,227→ 161,860 total
Footnotes (1)
- [F1]Represents restricted stock units ("RSU") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. Subject to the Reporting Person's continued service, the RSUs will vest over three years, with 1/3 vesting on each anniversary of June 3, 2026.